A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
NEJM 362:387-401, 456, Kappos, L.,et al, 2010
Use of Angiotension Receptor Blockers and Risk of Dementia in a Predominantly Male Population: Prospective Cohort Analysis
BMJ 340:141-147, 111, Li,N.-C.,et al, 2010
Clinicopath Conf, Infantile Krabbe Disease
NEJM 362:346-356, Case 3-2010, 2010
Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy at Stroke Onset
Stroke 41:288-294, Diedler,J.,et al, 2010
Effects of Early Intensive Blood Pressure-Lowering Treatment on the Growth of Hematoma and Perihematomal Edema in Acute Intracerebral Hemorrhage: The Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT)
Stroke 41:307-312, Anderson,C.S.,et al, 2010
Options to Restrict Hematoma Expansion After Spontaneous Intracerebral Hemorrhage
Stroke 41:402-409, Steiner,T. &B�sel,J., 2010
Practice Parameter: Pharmacologic Treatment of Spasticity in Children and Adolescents with Cerebral Palsy (an Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
Neurol 74:336-343, Delgado,M.R.,et al, 2010
Remote Supervision of IV-tPA for Acute Ischemic Stroke by Telemedicine or Telephone Before Transfer to a Regional Stroke Center Is Feasible and Safe
Stroke 41:e18-e24, Pervez,M.,et al, 2010
Recanalization Devices Should Be Restricted to Clinical Trials: Pro (Kind Of)
Stroke 41:191-193, 196, Schellinger,P. &Hacke,W., 2010
Clot Retrieval for Stroke Should Be Restricted to Clinical Trials: No
Stroke 41:194-195, 196, Furlan,A., 2010
Low Risk of Ipsilateral Stroke in Patients with Asymptomatic Carotid Stenosis on Best Medical Treatment: A Prospective, Population-Based Study
Stroke 41:e11-e17, Marquardt,L.,et al, 2010
Pulmonary AVMs, including hereditary hemorrhagic telangiectasia: Diagnosis and Treatment
UpTo Date, August, Gossage, J.R., 2010
Serum vitamin B12 and Folate Status in Patients with Inflammaotry Bowel Diseases
Eur J Med 21:320-323, Yakut, M.,et al, 2010
AIDS - Related Lymphomas: Primary CNS Lymphoma
UpToDate, April, Doweiko, J.P., 2010
Cogan Syndrome
www.medlink.com, Feb, Ramachandran, T.S., 2010
Primary Brain T-Cell Lymphoma of the Lymphoblastic Type Presenting as Altered Mental Status
Acta Neurochir 152:163-168, Clark, A.,et al, 2010
Compressive Myelopathy Mimicking Transverse Myelitis
Neurologist 16:120-122, Kelley, B.,et al, 2010
Perioperative Visual Loss in Ocular and Nonocular Surgery
Clin Ophthalmol 4:531-546, Berg, K.T.,et al, 2010
Impact od Adjuvant Chemotherapy for Gliomatosis Cerebri
BMC Cancer 10:424, Kong, D-S.,et al, 2010
Herpes Simplex Encephalitis during Treatment with Tumor Necrosis Factor- Inhibitors
CID 49:924-927, Bradford, R.D.,et al, 2009
Tumefactive Demyelination: An Approach to Diagnosis and Management
JNNP 84:1047-1053, Hardy, T.A. & Chataway, J., 2009
Nervous system dysfunction in Henoch-Schonlein Syndrome: Systematic review of the Literature
Rheumatol 48:1524-1529, Garzoni, L.,et al, 2009
Tempo of Disease. In Merritts Neurology. Signs and symptoms in neurologic diagnosis: Approach to the patient
, Rowland, L.P.,et al, 2009
Surgical Treatment for Renal Cancer Metastases
Actas Urol Esp 33:593-602, Ruiz-Cerda, J.L. & Jimenez Cruz, F., 2009
Lateral Sinus Thrombosis: Complication of Minor Head Injury
Int J Pediatr Otorhinolaryngol 73:629-635, Nehme, J.,et al, 2009
A Woman With Acute Myelopathy in Pregnancy: Case Outcome
BMJ 339:1372-1376, Reu�,R.,et al, 2009
Enzyme Replacement Therapy With Agalsidase Alfa in Patients With Fabrys Disease: An Analysis of Registry Data
Lancet 374:1986-1996, 1950, Mehta,A.,et al, 2009
Functional and Cognitive Outcome in Prolonged Refractory Status Epilepticus
Arch Neurol 66:1505-1509, Cooper,A.,et al, 2009
Nineteen Episodes of Recurrent Myelitis in a Woman with Neuromyelitis Optica and Systemic Lupus Erythematosus
Arch Neurol 66:1160-1163, Nasir, S.,et al, 2009
Treatment of Neuromyelitis Optica with Mycophenolate Mofetil
Arch Neurol 66:1128-1133, Jacob,A.,et al, 2009
Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab
NEJM 361:1075-1080, Wenning,W.,et al, 2009
Brainstem Lesions in Diffusion Sequences of MRI Can be Reversible After Arterial Recanalization
Neurol 73:813-815, Vilas,D., 2009
Combined Corticosteroid and Antiviral Treatment for Bell Palsy: A Systematic Review and Meta-analysis
JAMA 302:985-993, 1003, Almeida,J.,et al, 2009
Obesity Is a Common Comorbidity for Pediatric Patients with Untreated, Newly Diagnosed Epilepsy
Neurol 73:658-664, 654, Daniels, Z.S.,et al, 2009
Outcome of Symptomatic Intracranial Atherosclerotic Disease
Stroke 40:2983-2987, Samaniego,E.,et al, 2009
The Value of Specifying Brand-Name Antiepileptic Drugs
Arch Neurol 66:1415-1416, 1418, Ng,Y., 2009
Generic Anticonvulsant Use in Children: Do We Have Evidence to Recommend Brand Formulations?
Arch Neurol 66:1417-1418, Hamiwka,L., 2009
Multifocal Paraneoplastic Cortical Encephalitis Associated With Myasthenia Gravis and Thymoma
Arch Neurol 66:1407-1409, Hammoud,K.,et al, 2009
Leukodystrophies: Classification, Diagnosis, and Treatment
Neurologist 15:319-328, Costello,D.,et al, 2009
Patient Dissatisfaction with Acute Stroke Care
Stroke 40:3851-3856, Asplund,K.,et al, 2009
Systemic Review of the Perioperative Risks of Stroke or Death After Carotid Angioplasty and Stenting
Stroke 40:e683-e693, Touz�,E.,et al, 2009
Intravenous Thrombolysis in Stroke Attributable to Cervical Artery Dissection
Stroke 40:37772-3776, Engelter,S.,et al, 2009
Carotid Plaque Rupture
Lancet 374:1703, Keenan,N.,et al, 2009
Autism
Lancet 374:1627-1638, Levy,S.,et al, 2009
Imaging-Pathologic Correlation in Corticobasal Degeneration
AJNR 30:1884-1892, Tokumaru,A.,et al, 2009
Long-Term Outcome After Surgical Treatment for Space-Occupying Cerebellar Infarction: Experience in 56 Patients
Stroke 40:3060-3066, J�ttler,E.,et al, 2009
Long-Term Outcome After Suboccipital Decompressive Craniectomy for Malignant Cerebellar Infarction
Stroke 40:3045-3050, Pfefferkorn,T.,et al, 2009
Angiotensin Receptor Blockers Should Be Regarded as First-Line Drugs for Stroke Prevention in Both Primary and Secondary Prevention Settings: No
Stroke 40:3161-3162, 3163, Strauss,M. &Hall,A., 2009
Angiotensin Receptor Blockers Should Be Regarded as First-Line Drugs for Stroke Prevention in Both Primary and Secondary Prevention Settings: Yes
Stroke 40:3159-3160, 3163, Hackam,D., 2009
Intracranial Atherosclerotic Disease: An Update
Ann Neurol 66:730-738, Qureshi,A.,et al, 2009